Wall Street analyst · UBS

Paul Gong price targets & ratings

Paul Gong is a Wall Street equity research analyst at UBS, covering NIO, XPeng. Price Target holds 3 of these research notes since September 2025, each reproduced verbatim. Latest: UBS Initiates NIO H-Shares at Buy, HK$43 Price Target (Sep 11, 2026).

3 notes2 companiesSep 11 latest note

Career

Firms Paul Gong has published research under, with the period and number of notes Price Target holds for each.

  • UBSSeptember 2025 – present notes on Price Target3 notes

Current calls

Latest rating and price target on each company, with the implied move from the last share price.

NIONIOBuyHK$43—Sep 11, 20262
XPengXPEVHold——Sep 9, 20261

Track record

Price targets are 12-month calls, so they are scored once they are a year old. Most recent first. How we score

By year of the call
YearTargetsScoredReachedStill open
2025110 (0%)—
CompanyNoteTarget12-month result
NIOSep 16, 2025$8.50✗ Not reached in 12 months

Notes by Paul Gong 3

Questions about Paul Gong

Who is Paul Gong?

Paul Gong is an equity research analyst at UBS, covering NIO, XPeng. Price Target holds 3 research notes by Paul Gong, the earliest from September 2025.

Which stocks does Paul Gong cover?

In the notes Price Target holds, Paul Gong covers 2 companies: NIO, XPeng.

How accurate are Paul Gong’s price targets?

Price targets are 12-month calls, so Price Target scores each one once it is a year old. Paul Gong has 1 target that old in our archive so far, too few to give a rate. How we score

What is Paul Gong’s latest price target?

The most recent price target from Paul Gong in our archive is HK$43 on NIO, with a Buy rating, published September 11, 2026. Read the note

All Wall Street analysts · All UBS notes · Most accurate firms

Price Target is an archive of Wall Street analyst research, published for informational purposes only. Nothing on this site is investment advice, a recommendation, or an offer to buy or sell any security. Analyst ratings and price targets are the opinions of the issuing firms, not of Price Target. Always do your own research or consult a licensed financial adviser.